IFAKARA HEALTH INSTITUTE
š¹šæTanzania
- Country
- š¹šæTanzania
- Ownership
- Private
- Established
- 1949-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.ihi.or.tz
Clinical Trials
13
Active:0
Completed:5
Trial Phases
5 Phases
Phase 1:3
Phase 2:1
Phase 3:3
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)ā¢ Click on a phase to view related trials
Not Applicable
5 (38.5%)Phase 1
3 (23.1%)Phase 3
3 (23.1%)Phase 2
1 (7.7%)Phase 4
1 (7.7%)In-vivo Transmission Model in Semi-immune Adults
Phase 1
Not yet recruiting
- Conditions
- Controlled Human Malaria InfectionInduced Blood Stage Malaria InfectionMalaria TransmissionMalaria Challenge
- Interventions
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Ifakara Health Institute
- Target Recruit Count
- 24
- Registration Number
- NCT06172686
- Locations
- š¹šæ
Ifakara Health Institute, Pwani, Tanzania
Evaluation of Insecticide-treated Eave Nets and Window Screens for Malaria Control in Tanzania.
Not Applicable
- Conditions
- Malaria,Falciparum
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2021-12-02
- Lead Sponsor
- Ifakara Health Institute
- Target Recruit Count
- 1800
- Registration Number
- NCT05125133
- Locations
- š¹šæ
Vector Control Product Testing Unit Facility, Bagamoyo, Tanzania
Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Ifakara Health Institute
- Target Recruit Count
- 12
- Registration Number
- NCT04944966
- Locations
- š¹šæ
Bagamoyo Clinical Trial Facility, Bagamoyo, Tanzania
Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents for Malaria Prevention
Phase 3
- Conditions
- Malaria
- First Posted Date
- 2016-10-19
- Last Posted Date
- 2017-06-06
- Lead Sponsor
- Ifakara Health Institute
- Target Recruit Count
- 1500
- Registration Number
- NCT02938975
- Locations
- š¹šæ
Ifakara Health Institute, Bagamoyo, Tanzania
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
Phase 3
- Conditions
- Iron-Deficiency Anemia
- Interventions
- Drug: Ferrous sulfate + folic acid
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Ifakara Health Institute
- Target Recruit Count
- 230
- Registration Number
- NCT02541708
- Locations
- š¹šæ
Ifakara Health Institute, Bagamoyo, Tanzania
- Prev
- 1
- 2
- Next
News
No news found